Literature DB >> 29579305

Seizure outcomes of supratentorial brain tumor resection in pediatric patients.

Fadi S Saadeh1,2, Edward F Melamed1,2, Nolan D Rea1,2, Mark D Krieger1,2.   

Abstract

Background: This study aims to identify the prevalence of and risk factors for seizure development after supratentorial brain tumor resection in pediatric patients. This could be used to guide the postoperative management and usage of anti-epileptic drugs (AEDs).
Methods: Retrospective study was conducted for patients between 0 and 21 years with supratentorial tumor resection between 2005 and 2015 at a single institution.
Results: Two hundred patients (114 males/86 females) were identified. Median age at resection (±SD) was 9.025 ± 5.720 years and mean follow-up was 4 ± 2 years. Resection was gross total in 82 patients (41%) and partial in 118 patients (59%); 66 patients (33%) experienced preoperative seizures, and 67 patients (34%) experienced postoperative seizures; 18 patients (27%) had early seizures, and 49 patients (73%) had late seizures. Univariate analysis identified risk factors for postoperative seizures as: preoperative seizures (P < 0.001), age less than 2 years (P = 0.003), temporal location (P < 0.001), thalamic location (P = 0.017), preoperative hyponatremia (P = 0.017), World Health Organization grade (P = 0.008), and pathology (P = 0.005). Multivariate regression identified 5 robust risk factors: temporal location (odds ratio [OR] 4.7, 95% CI: 1.7-13.3, P = 0.003), age <2 years (OR 3.9, 95% CI: 1.0-15.4; P = 0.049), preoperative hydrocephalus (OR 3.8, 95% CI: 1.5-9.4; P = 0.005), preoperative seizure (OR 2.8, 95% CI: 1.2-6.5; P = 0.016) and parietal location (OR 0.25, 95% CI: 0.06-0.99; P = 0.049). Extent of resection did not correlate with seizure development (P > 0.05). Conclusions: This study reveals 5 risk factors for postoperative seizures after resection of supratentorial tumors. These factors should be considered in postoperative management of these patients.

Entities:  

Mesh:

Year:  2018        PMID: 29579305      PMCID: PMC6071648          DOI: 10.1093/neuonc/noy026

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  36 in total

1.  Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study.

Authors:  Antonio De Santis; Roberto Villani; Marco Sinisi; Nino Stocchetti; Emilio Perucca
Journal:  Epilepsia       Date:  2002-02       Impact factor: 5.864

Review 2.  Three distinct roles of aquaporin-4 in brain function revealed by knockout mice.

Authors:  A S Verkman; Devin K Binder; Orin Bloch; Kurtis Auguste; Marios C Papadopoulos
Journal:  Biochim Biophys Acta       Date:  2006-03-10

3.  Aquaporin-4 expression is increased in oedematous human brain tumours.

Authors:  S Saadoun; M C Papadopoulos; D C Davies; S Krishna; B A Bell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 4.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

5.  Seizures in children with primary brain tumors: incidence and long-term outcome.

Authors:  Raja B Khan; Daniel L Hunt; Frederick A Boop; Robert A Sanford; Thomas E Merchant; Amar Gajjar; Larry E Kun
Journal:  Epilepsy Res       Date:  2005-05       Impact factor: 3.045

6.  Seizures following posterior fossa surgery.

Authors:  A Suri; A K Mahapatra; P Bithal
Journal:  Br J Neurosurg       Date:  1998-02       Impact factor: 1.596

7.  Aquaporin-4 contributes to the resolution of peritumoural brain oedema in human glioblastoma multiforme after combined chemotherapy and radiotherapy.

Authors:  Beatrice Nico; Domenica Mangieri; Roberto Tamma; Vito Longo; Tiziana Annese; Enrico Crivellato; Bianca Pollo; Emanuela Maderna; Domenico Ribatti; Andrea Salmaggi
Journal:  Eur J Cancer       Date:  2009-10-14       Impact factor: 9.162

8.  Thalamic tumors in children: a reappraisal.

Authors:  Stephanie Puget; Darach W Crimmins; Matthew R Garnett; Jacques Grill; Ricardo Oliveira; Nathalie Boddaert; Alison Wray; Arielle Lelouch-Tubiana; Thomas Roujeau; Federico Di Rocco; Michel Zerah; Christian Sainte-Rose
Journal:  J Neurosurg       Date:  2007-05       Impact factor: 5.115

9.  Postoperative epilepsy: a double-blind trial of phenytoin after craniotomy.

Authors:  J B North; R K Penhall; A Hanieh; C S Hann; R G Challen; D B Frewin
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

Review 10.  Aquaporin-4 and brain edema.

Authors:  Marios C Papadopoulos; Alan S Verkman
Journal:  Pediatr Nephrol       Date:  2007-03-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.